力诺特玻(301188) - 2022年11月16日投资者关系活动记录表

Group 1: Company Projects and Developments - The company has successfully launched several new projects, including a fully electric intelligent pharmaceutical glass production line, which began operations in July 2022, aimed at reducing production costs for low borosilicate glass [1][3]. - The molded bottle project was initiated in August 2022 and has received regulatory approval as of October 18, 2022, with production currently underway [3][4]. - The mid-borosilicate glass tube project was successfully launched in October 2022 and is progressing as planned [3][4]. Group 2: Financial Performance and Market Strategy - The company aims to enhance shareholder value by expanding its capacity in the molded bottle sector through the construction of a "Phase III Project" [3][5]. - The company has adopted a sales-driven production model, aligning production with market demand and customer orders [5][6]. - Despite facing challenges due to external uncertainties, the company is committed to achieving its operational goals and improving cost efficiency [6]. Group 3: Investor Relations and Communication - The company emphasizes the importance of communication with investors and plans to enhance its information disclosure quality [4][5]. - There has been no notification from shareholders regarding any plans to reduce their holdings following the lifting of restrictions on November 11, 2022 [3][4]. - The company is actively monitoring its stock price trends and is focused on maintaining investor confidence and market recognition of its intrinsic value [4][5].